IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction
Authors
Keywords
-
Journal
PROSTATE
Volume 75, Issue 8, Pages 883-895
Publisher
Wiley
Online
2015-02-15
DOI
10.1002/pros.22971
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of VCAM-1 and Its Associated Molecule CD44 Leads to Increased Malignant Potential of Breast Cancer Cells
- (2014) Pei-Chen Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment
- (2014) Qiuyang Zhang et al. PROSTATE
- AZD5363 Inhibits Inflammatory Synergy between Interleukin-17 and Insulin/Insulin-Like Growth Factor 1
- (2014) Chong Chen et al. Frontiers in Oncology
- IL-17A Induces Endothelial Inflammation in Systemic Sclerosis via the ERK Signaling Pathway
- (2013) Xiaojing Xing et al. PLoS One
- Interleukin-17 Promotes Formation and Growth of Prostate Adenocarcinoma in Mouse Models
- (2012) Q. Zhang et al. CANCER RESEARCH
- Obesity, type 2 diabetes, and cancer: the insulin and IGF connection
- (2012) Dara Hope Cohen et al. ENDOCRINE-RELATED CANCER
- The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α
- (2012) Shu Zhu et al. NATURE MEDICINE
- Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database
- (2011) Christopher J. Keto et al. BJU INTERNATIONAL
- Insulin augments tumor necrosis factor-alpha stimulated expression of vascular cell adhesion molecule-1 in vascular endothelial cells
- (2011) Daniel Z Mackesy et al. Journal of Inflammation-London
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- Transiently Entrapped Circulating Tumor Cells Interact with Neutrophils to Facilitate Lung Metastasis Development
- (2010) S. J. Huh et al. CANCER RESEARCH
- Optimization of Formaldehyde Cross-Linking for Protein Interaction Analysis of Non-Tagged Integrinβ1
- (2010) Cordula Klockenbusch et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- IL-17RC Is Required for Immune Signaling via an Extended SEF/IL-17R Signaling Domain in the Cytoplasmic Tail
- (2010) A. W. Ho et al. JOURNAL OF IMMUNOLOGY
- IL-17 Promotes p38 MAPK-Dependent Endothelial Activation Enhancing Neutrophil Recruitment to Sites of Inflammation
- (2010) L. Roussel et al. JOURNAL OF IMMUNOLOGY
- Immune and Inflammatory Mechanisms of Atherosclerosis
- (2009) Elena Galkina et al. Annual Review of Immunology
- IL-17 Receptor Signaling Inhibits C/EBP by Sequential Phosphorylation of the Regulatory 2 Domain
- (2009) F. Shen et al. Science Signaling
- Act1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling
- (2009) C. Liu et al. Science Signaling
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
- (2008) E M Hurt et al. BRITISH JOURNAL OF CANCER
- Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women
- (2008) M Sumarac-Dumanovic et al. INTERNATIONAL JOURNAL OF OBESITY
- Carcinoembryonic Antigen and CD44 Variant Isoforms Cooperate to Mediate Colon Carcinoma Cell Adhesion to E- and L-selectin in Shear Flow
- (2008) Susan N. Thomas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now